Interference with Oral Anticoagulant Treatment by Oestrogen – Influence of Oestrogen Administration Route

• References

• 1 Kroon U-B, Silfverstolpe G, Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb Haemost 1994; 71: 420-3.
• 2 Scarabin P-Y, Plu-Bureau G, Bara L, Bonithonn-Kopp C, Guize L, Samama MM. Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemost 1993; 70: 584-7.
• 3 Pacifici GM, Viani A, Rizzo G, Carrai M. Plasma protein binding of ethinyloestradiol: effect of disease and interaction with drugs. Int J Clin Pharmacol Ther Toxicol 1989; 27: 362-5.
• 4 De Lignieres B, Basdevant A, Thomas G, Thalabard J-C, Mercier-Bodard C, Conard J, Guyene T-T, Mairon N, Corvol P, Guy-Grand B, MauvaiS-Jarvis P, Sitruk-Ware R. Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 1986; 62: 536-41.
• 5 De Teresa E, Vera A, Ortigosa J, Alonso Pulpon L, Puente Arus A, De Artaza M. Interaction between anticoagulants and contraceptives: an unsuspected finding. Br Med J 1979; 2: 1260-1.